Molina Healthcare, Inc (NYSE:MOH – Get Free Report) has received an average rating of “Hold” from the fourteen research firms that are currently covering the stock, MarketBeat Ratings reports. Two analysts have rated the stock with a sell recommendation, ten have assigned a hold recommendation and two have assigned a buy recommendation to the company. The average 1 year price objective among brokers that have updated their coverage on the stock in the last year is $157.8571.
Several equities analysts have commented on the stock. Wells Fargo & Company set a $141.00 price objective on shares of Molina Healthcare and gave the company an “equal weight” rating in a research report on Friday. Barclays decreased their target price on shares of Molina Healthcare from $164.00 to $133.00 and set an “underweight” rating on the stock in a research report on Tuesday, February 10th. UBS Group reiterated a “neutral” rating and issued a $145.00 price target on shares of Molina Healthcare in a research report on Monday, February 9th. Mizuho set a $220.00 price objective on Molina Healthcare in a research report on Friday, January 9th. Finally, Truist Financial lowered their price objective on Molina Healthcare from $190.00 to $145.00 and set a “hold” rating for the company in a research note on Tuesday, February 17th.
Read Our Latest Research Report on Molina Healthcare
Institutional Inflows and Outflows
Molina Healthcare Price Performance
Shares of Molina Healthcare stock opened at $156.53 on Tuesday. The firm has a market cap of $8.06 billion, a PE ratio of 18.29 and a beta of 0.49. The stock has a 50 day moving average of $168.95 and a 200 day moving average of $169.01. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.97. Molina Healthcare has a 12 month low of $121.06 and a 12 month high of $359.97.
Molina Healthcare (NYSE:MOH – Get Free Report) last released its quarterly earnings data on Thursday, February 5th. The company reported ($2.75) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.43 by ($3.18). The firm had revenue of $11.38 billion during the quarter, compared to the consensus estimate of $10.90 billion. Molina Healthcare had a return on equity of 13.60% and a net margin of 1.04%.The business’s revenue was up 8.3% compared to the same quarter last year. During the same period in the previous year, the firm earned $5.05 EPS. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. On average, research analysts expect that Molina Healthcare will post 24.4 EPS for the current fiscal year.
About Molina Healthcare
Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.
The company traces its roots to the early 1980s, when Dr.
Featured Stories
- Five stocks we like better than Molina Healthcare
- Elon Musk already made me a “wealthy man”
- Unlocked: Elon Musk’s Next Big IPO
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- What Expenses Can Be Deducted From Capital Gains Tax This Year?
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
